Audit 323164

FY End
2023-12-31
Total Expended
$2.64M
Findings
2
Programs
1
Year: 2023 Accepted: 2024-09-30

Organization Exclusion Status:

Checking exclusion status...

Findings

ID Ref Severity Repeat Requirement
500401 2023-001 - - A
1076843 2023-001 - - A

Programs

ALN Program Spent Major Findings
93.498 Provider Relief Fund $2.64M Yes 1

Contacts

Name Title Type
EWAJLQNK6BJ6 Ibi Khan Auditee
4104022121 Victoria Brennan Auditor
No contacts on file

Notes to SEFA

Title: 1. Basis of Presentation Accounting Policies: The accompanying Schedule of Expenditures of Federal Awards (the “Schedule”) summarizes the federal expenditures of Riderwood Village, Inc. and Subsidiary (“RWV”) under programs of the federal government for the year ended December 31, 2023. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a selected portion of the operations of RWV, it is not intended to and does not present the financial position, the results of its operations and the cash flows of RWV. For purposes of the Schedule, federal awards include all awards in the form of grants, contracts, and similar agreements entered into directly between RWV and agencies and departments of the federal government and non-federal pass-through entities. Federal Assistance Listing and pass-through identification numbers are included when available. De Minimis Rate Used: N Rate Explanation: For the purpose of the Schedule, expenditures for federal award programs are recognized on the accrual basis of accounting. RWV has not elected to use the 10% de minimis rate for indirect costs. Indirect costs are not applicable for RWV’s expenditure reporting. The accompanying Schedule of Expenditures of Federal Awards (the “Schedule”) summarizes the federal expenditures of Riderwood Village, Inc. and Subsidiary (“RWV”) under programs of the federal government for the year ended December 31, 2023. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a selected portion of the operations of RWV, it is not intended to and does not present the financial position, the results of its operations and the cash flows of RWV. For purposes of the Schedule, federal awards include all awards in the form of grants, contracts, and similar agreements entered into directly between RWV and agencies and departments of the federal government and non-federal pass-through entities. Federal Assistance Listing and pass-through identification numbers are included when available.
Title: 2. Summary of Significant Accounting Policies Accounting Policies: The accompanying Schedule of Expenditures of Federal Awards (the “Schedule”) summarizes the federal expenditures of Riderwood Village, Inc. and Subsidiary (“RWV”) under programs of the federal government for the year ended December 31, 2023. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a selected portion of the operations of RWV, it is not intended to and does not present the financial position, the results of its operations and the cash flows of RWV. For purposes of the Schedule, federal awards include all awards in the form of grants, contracts, and similar agreements entered into directly between RWV and agencies and departments of the federal government and non-federal pass-through entities. Federal Assistance Listing and pass-through identification numbers are included when available. De Minimis Rate Used: N Rate Explanation: For the purpose of the Schedule, expenditures for federal award programs are recognized on the accrual basis of accounting. RWV has not elected to use the 10% de minimis rate for indirect costs. Indirect costs are not applicable for RWV’s expenditure reporting. For the purpose of the Schedule, expenditures for federal award programs are recognized on the accrual basis of accounting. RWV has not elected to use the 10% de minimis rate for indirect costs. Indirect costs are not applicable for RWV’s expenditure reporting.
Title: 3. U.S. Department of Health and Human Services (HHS) Awards for the COVID-19 Provider Relief Fund and American Rescue Plan Rural Distribution Program Accounting Policies: The accompanying Schedule of Expenditures of Federal Awards (the “Schedule”) summarizes the federal expenditures of Riderwood Village, Inc. and Subsidiary (“RWV”) under programs of the federal government for the year ended December 31, 2023. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a selected portion of the operations of RWV, it is not intended to and does not present the financial position, the results of its operations and the cash flows of RWV. For purposes of the Schedule, federal awards include all awards in the form of grants, contracts, and similar agreements entered into directly between RWV and agencies and departments of the federal government and non-federal pass-through entities. Federal Assistance Listing and pass-through identification numbers are included when available. De Minimis Rate Used: N Rate Explanation: For the purpose of the Schedule, expenditures for federal award programs are recognized on the accrual basis of accounting. RWV has not elected to use the 10% de minimis rate for indirect costs. Indirect costs are not applicable for RWV’s expenditure reporting. The Schedule includes grant activity related to the Department of Health and Human Services ("HHS") COVID-19 Provider Relief Fund and American Rescue Plan (ARP) Rural Distribution Assistance Listing Number 93.498. As required based on guidance in the 2023 OMB Compliance Supplement, the Schedule includes all Period 5 funds received between January 1, 2022 and June 30, 2022 and expended by June 30, 2023 and all Period 6 Funds received between July 1, 2022 and December 31, 2022 and expended by December 31, 2023 as reported to Health Resources and Services Administration (“HRSA”) via the PRF Reporting Portal. The grant activity associated with this Assistance Listing # can include lost revenues and direct expenditures. The total amount recognized in the Schedule of $2,641,096 for the year ended December 31, 2023, included only direct expenditures.

Finding Details

Criteria Per the OMB Compliance Supplement 2 CFR Part 200 Appendix XI, Activities allowed for Provider Relief Funds include funds that are available for building or construction of temporary structures, leasing of properties, medical supplies and equipment, including personal protective equipment and testing supplies, increased workforce and trainings, emergency operation centers, retrofitting facilities, and surge capacity. Recipients must use the funding for the following conditions: • Payment will only be used to prevent, prepare for, and respond to coronavirus and COVID-19, and that the payment shall reimburse the recipient only for health care related expenses or lost revenues that are attributable to coronavirus and COVID-19 • The recipient certifies that retaining the payment for at least 90 days without contacting HHS regarding remittance of those funds, is deemed to have accepted the Terms and Conditions • The recipient must provide or have provided after January 31, 2020, diagnoses, testing, or care for individuals with possible or actual cases of COVID-19. The Department of Health and Human Services (HHS) broadly views every patient as a possible case of COVID-19 Condition In reporting period 5, 1 employee out of 27 employees tested received a stay bonus as compensation that was not initially authorized. The employee was authorized $0 and received $203. Upon review of all employees, 14 were authorized $0 and received a total of $4.3K. Cause Management performed an initial authorization of employees to receive the stay bonus compensation. Included on the authorized list were employees to receive $0 of the stay bonus compensation. This was based on their position. After the initial approval of the stay bonus compensation, it was determined that additional individuals were to receive the stay bonus compensation based on duties performed. Subsequent approval was provided for the employees after the stay bonus payment was dispersed to them. This was considered to be a finding for the late approval. Effect As timely approval was not provided, the stay bonus for the employee that was received as compensation was not approved or authorized. Per the OMB Compliance Supplement referenced above, this employee could have been somebody that was not allowable and should not have received the compensation. Questioned Costs There are no questioned costs associated with this finding as the exception noted relates to the timeliness of approval. Recommendation We recommend that Management evaluates all employees authorized $0 of stay bonus compensation to ensure any receiving more had the appropriate authorization to be paid.
Criteria Per the OMB Compliance Supplement 2 CFR Part 200 Appendix XI, Activities allowed for Provider Relief Funds include funds that are available for building or construction of temporary structures, leasing of properties, medical supplies and equipment, including personal protective equipment and testing supplies, increased workforce and trainings, emergency operation centers, retrofitting facilities, and surge capacity. Recipients must use the funding for the following conditions: • Payment will only be used to prevent, prepare for, and respond to coronavirus and COVID-19, and that the payment shall reimburse the recipient only for health care related expenses or lost revenues that are attributable to coronavirus and COVID-19 • The recipient certifies that retaining the payment for at least 90 days without contacting HHS regarding remittance of those funds, is deemed to have accepted the Terms and Conditions • The recipient must provide or have provided after January 31, 2020, diagnoses, testing, or care for individuals with possible or actual cases of COVID-19. The Department of Health and Human Services (HHS) broadly views every patient as a possible case of COVID-19 Condition In reporting period 5, 1 employee out of 27 employees tested received a stay bonus as compensation that was not initially authorized. The employee was authorized $0 and received $203. Upon review of all employees, 14 were authorized $0 and received a total of $4.3K. Cause Management performed an initial authorization of employees to receive the stay bonus compensation. Included on the authorized list were employees to receive $0 of the stay bonus compensation. This was based on their position. After the initial approval of the stay bonus compensation, it was determined that additional individuals were to receive the stay bonus compensation based on duties performed. Subsequent approval was provided for the employees after the stay bonus payment was dispersed to them. This was considered to be a finding for the late approval. Effect As timely approval was not provided, the stay bonus for the employee that was received as compensation was not approved or authorized. Per the OMB Compliance Supplement referenced above, this employee could have been somebody that was not allowable and should not have received the compensation. Questioned Costs There are no questioned costs associated with this finding as the exception noted relates to the timeliness of approval. Recommendation We recommend that Management evaluates all employees authorized $0 of stay bonus compensation to ensure any receiving more had the appropriate authorization to be paid.